<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92308">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01779154</url>
  </required_header>
  <id_info>
    <org_study_id>136132</org_study_id>
    <nct_id>NCT01779154</nct_id>
  </id_info>
  <brief_title>Eosinophilic Gastrointestinal Disorders Patient Registry</brief_title>
  <official_title>Eosinophilic Gastrointestinal Disorders Patient Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arkansas Children's Hospital Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Arkansas Children's Hospital Research Institute</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Eosinophilic Gastrointestinal Disorders (EGIDS) Registry is a longitudinal study that
      does not involve medical interventions, but serves as a record of demographics,
      characteristics of disease and treatment, utilization patterns, quality improvement measures
      and clinical outcomes.  The database is proposed so that epidemiologic research can be
      performed and current and accurate data can be obtained regarding practice patterns, age and
      gender distributions, efficacy of treatment, clinical outcomes and changes in quality of
      life.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>21 Years</target_duration>
  <primary_outcome>
    <measure>To define characteristics of an eosinophilic gastrointestinal disorder population in a rural southern state</measure>
    <time_frame>After 12 months of data collection</time_frame>
    <safety_issue>No</safety_issue>
    <description>To develop a database of patients with eosinophilic gastrointestinal disorders so that epidemiologic research can be performed and current data can be obtained regarding practice patterns, age and gender distributions, efficacy of treatment, clinical outcomes and changes in quality of life.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Eosinophilic Esophagitis</condition>
  <condition>Eosinophilic Gastritis</condition>
  <condition>Eosinophilic Enteritis</condition>
  <condition>Eosinophilic Colitis</condition>
  <arm_group>
    <arm_group_label>eosinophilic gastrointestinal disorders</arm_group_label>
    <description>Individuals with a diagnosis of EGID including: eosinophilic esophagitis, eosinophilic gastritis, eosinophilic enteritis, eosinophilic colitis</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals with a diagnosis of an eosinophilic gastrointestinal disorder
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male or female participants of any race or ethnicity

          -  age 0 to 21 years

          -  diagnosis of EGID including: eosinophilic esophagitis, eosinophilic gastritis,
             eosinophilic enteritis, eosinophilic colitis

        Exclusion Criteria:

          -  hypereosinophilic syndrome

          -  non-eosinophilic gastrointestinal or allergic disorder
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robbie D Pesek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arkansas for Medical Sciences / Arkansas Children's Hospital Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Arkansas Children's Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 26, 2013</lastchanged_date>
  <firstreceived_date>January 28, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>eosinophilic esophagitis</keyword>
  <keyword>eosinophilic gastritis</keyword>
  <keyword>eosinophilic enteritis</keyword>
  <keyword>eosinophilic colitis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Enteritis</mesh_term>
    <mesh_term>Esophagitis</mesh_term>
    <mesh_term>Gastritis</mesh_term>
    <mesh_term>Digestive System Diseases</mesh_term>
    <mesh_term>Gastrointestinal Diseases</mesh_term>
    <mesh_term>Eosinophilic Esophagitis</mesh_term>
    <mesh_term>Eosinophilia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
